TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/18/2025
Back to search
Official data from USPTO
TAYSHA GENE THERAPIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TAYSHA GENE THERAPIES
ST13
US500000090773805Class
5
Filing
90773805
Registration
7502769
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
12/19/2025
Trademark type
Word
Nice classes
5
Filing date
06/15/2021
Registration date
09/10/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/20/2023
First use in commerce
12/20/2023
Drawing code
4
Owner type
03
Owner location
Dallas, TX
Examiner
SMITH,REBECCA A
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Taysha Gene Therapies, Inc.
Representatives
John L. DuPre' HAMILTON, BROOK, SMITH & REYNOLDS, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and pharmaceutical preparations for use in the treatment of genetic diseases and disorders
Publications
History of USPTO decisions and trademark events.
39 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/18/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/16/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/13/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/10/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/26/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/25/2024
IUAF
USE AMENDMENT FILED
01/05/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2023
EX3G
SOU EXTENSION 3 GRANTED
11/07/2023
EXT3
SOU EXTENSION 3 FILED
11/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/20/2023
EX2G
SOU EXTENSION 2 GRANTED
04/18/2023
EXT2
SOU EXTENSION 2 FILED
04/18/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/18/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/10/2022
EX1G
SOU EXTENSION 1 GRANTED
11/08/2022
EXT1
SOU EXTENSION 1 FILED
11/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/08/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2022
PUBO
PUBLISHED FOR OPPOSITION
04/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/08/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/08/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/08/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/08/2022
DOCK
ASSIGNED TO EXAMINER
03/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2021
NWAP
NEW APPLICATION ENTERED
06/18/2021
Continuous trademark protection
Get notified about every new filing that threatens TAYSHA GENE THERAPIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.